Immunology, Cytotoxic T cell, Virology, Antigen and Epitope are his primary areas of study. When carried out as part of a general Immunology research project, his work on Epstein–Barr virus, Virus, Immune system and Immunotherapy is frequently linked to work in Reed–Sternberg cell, therefore connecting diverse disciplines of study. The various areas that Rajiv Khanna examines in his Cytotoxic T cell study include T lymphocyte and CD8.
His CD8 research is multidisciplinary, relying on both Cancer research and Antigen-presenting cell. His Antigen research incorporates elements of Lymphoproliferative disorders and Lytic cycle. His Epitope study combines topics in areas such as Vaccinia, Orthopoxvirus, Human leukocyte antigen, CTL* and Major histocompatibility complex.
Rajiv Khanna focuses on Immunology, Virology, Cytotoxic T cell, Antigen and Epitope. His study in Immunology concentrates on Immune system, T cell, Immunotherapy, Immunity and Human cytomegalovirus. Virology connects with themes related to Vaccinia in his study.
Rajiv Khanna interconnects Cancer research, CD8 and Major histocompatibility complex in the investigation of issues within Cytotoxic T cell. His Antigen study incorporates themes from Peptide sequence, Antigen-presenting cell and T-cell receptor. In Epitope, Rajiv Khanna works on issues like Antigen presentation, which are connected to Cell biology.
His main research concerns T cell, Immunology, Immune system, Antigen and Virology. Rajiv Khanna has included themes like Congenital cytomegalovirus infection, Cancer research, Internal medicine and Immunotherapy in his T cell study. His biological study spans a wide range of topics, including Epitope, Computational biology and Transplantation.
His Epitope study integrates concerns from other disciplines, such as Cytotoxic T cell and Human leukocyte antigen. His Antigen research includes themes of In vitro and Oncology. His Virology research is mostly focused on the topic Virus.
His primary areas of investigation include T cell, Immunology, Immune system, Transplantation and Immunity. His study in T cell is interdisciplinary in nature, drawing from both Immunohistochemistry, Virus, Virology and Cancer research. His Immune system research incorporates themes from Internal medicine, Adverse effect, Clinical trial and Drug resistance.
The concepts of his Transplantation study are interwoven with issues in Congenital cytomegalovirus infection, Phases of clinical research and T-cell receptor. Rajiv Khanna has researched Immunity in several fields, including In vitro, Cellular immunity, Coronavirus disease 2019, Severe acute respiratory syndrome coronavirus 2 and Memory T cell. His CD8 study contributes to a more complete understanding of Antigen.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments
Maher K Gandhi;Rajiv Khanna.
Lancet Infectious Diseases (2004)
Immunobiology of Human Cytomegalovirus: from Bench to Bedside
Tania Crough;Rajiv Khanna.
Clinical Microbiology Reviews (2009)
Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.
R Khanna;S R Burrows;M G Kurilla;C A Jacob.
Journal of Experimental Medicine (1992)
Herpesvirus-Specific CD8 T Cell Immunity in Old Age: Cytomegalovirus Impairs the Response to a Coresident EBV Infection
Naeem Khan;Andrew Hislop;Nancy Gudgeon;Mark Cobbold.
Journal of Immunology (2004)
Ex Vivo Profiling of CD8+-T-Cell Responses to Human Cytomegalovirus Reveals Broad and Multispecific Reactivities in Healthy Virus Carriers
Rebecca Elkington;Susan Walker;Tania Crough;Moira Menzies.
Journal of Virology (2003)
Activation and adoptive transfer of Epstein–Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease
Rajiv Khanna;Scott Bell;Martina Sherritt;Andrew Galbraith.
Proceedings of the National Academy of Sciences of the United States of America (1999)
An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease.
S R Burrows;R Khanna;J M Burrows;D J Moss.
Journal of Experimental Medicine (1994)
Immune regulation in Epstein-Barr virus-associated diseases.
R Khanna;S R Burrows;D J Moss.
Microbiological Research (1995)
HLA-B27–Restricted Antigen Presentation in the Absence of Tapasin Reveals Polymorphism in Mechanisms of HLA Class I Peptide Loading
Chen Au Peh;Scott R Burrows;Megan Barnden;Rajiv Khanna.
Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein‐Barr virus latent membrane protein‐1: coordinate up‐regulation of peptide transporters and HLA‐class I antigen expression
Martin Rowe;Rajiv Khanna;Catherine A. Jacob;Victor Argaet.
European Journal of Immunology (1995)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: